Literature DB >> 11554615

CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells.

K J Chou1, L L Tseng, J S Cheng, J L Wang, H C Fang, K C Lee, W Su, Y P Law, C R Jan.   

Abstract

The effect of CP55,940, a presumed CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels ([Ca2+]i) in Madin-Darby canine kidney cells was examined by using the fluorescent dye fura-2 as a Ca2+ indicator. CP55,940 (2-50 microM) increased [Ca2+]i concentration-dependently with an EC50 of 8 microM. The [Ca2+]i signal comprised an initial rise and a sustained phase. Extracellular Ca2+ removal decreased the maximum [Ca2+]i signals by 32+/-12%. CP55,940 (20 microM)-induced [Ca2+]i signal was not altered by 5 microM of two cannabinoid receptor antagonists, AM-251 and AM-281. CP55,940 (20 microM)-induced [Ca2+]i increase in Ca2+-free medium was inhibited by 86+/-3% by pretreatment with 1 microM thapsigargin, an endoplasmic reticulum Ca2+ pump inhibitor. Conversely, pretreatment with 20 microM CP55,940 in Ca2+-free medium for 6 min abolished thapsigargin-induced [Ca2+]i increases. CP55,940 (20 microM)-induced intracellular Ca2+ release was not inhibited when inositol 1,4,5-trisphosphate formation was abolished by suppressing phospholipase C with 2 microM U73122. Collectively, this study shows that CP,55940 induced significant [Ca2+]i increases in canine renal tubular cells by releasing stored Ca2+ from the thapsigargin-sensitive pools in an inositol 1,4,5-trisphosphate-independent manner, and also by causing extracellular Ca2+ entry. The CP55,940's action appears to be dissociated from stimulation of cannabinoid receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554615     DOI: 10.1016/s0024-3205(01)01242-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.

Authors:  Paola Nieri; Nadia Romiti; Barbara Adinolfi; Andrea Chicca; Ilaria Massarelli; Elisabetta Chieli
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells.

Authors:  Effimia Gkoumassi; Bart G J Dekkers; Melloney J Dröge; Carolina R S Elzinga; Rutger E Hasenbosch; Herman Meurs; S Adriaan Nelemans; Martina Schmidt; Johan Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-03       Impact factor: 3.000

3.  Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells.

Authors:  Zebing Huang; Haiyan Wang; Jingke Wang; Mengqin Zhao; Nana Sun; Fangfang Sun; Jianxin Shen; Haiying Zhang; Kunkun Xia; Dejie Chen; Ming Gao; Ronald P Hammer; Qingrong Liu; Zhengxiong Xi; Xuegong Fan; Jie Wu
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

4.  Dose-Dependent Cannabidiol-Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes.

Authors:  Martina Winklmayr; Martin Gaisberger; Michael Kittl; Julia Fuchs; Markus Ritter; Martin Jakab
Journal:  J Orthop Res       Date:  2019-08-26       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.